Processa Pharmaceuticals, Inc. is a development-stage pharmaceutical company based in Hanover, MD, dedicated to improving the quality of life for patients with unmet medical needs. With a focus on oncology and other high unmet medical need diseases, Processa uses a unique approach to develop effective pharmacological solutions, leveraging unparalleled regulatory science and clinical expertise. Their drug candidates, such as PCS6422 for metastatic colorectal and breast cancer, aim to provide safer and more effective treatment options for patients with limited treatment options.
Processa Pharmaceuticals' leadership team, with over 30 years of experience, is driven by a common goal to help patients suffering from life-threatening and life-compromising chronic diseases. They prioritize unmet medical needs for patients and caregivers, allocating resources to accelerate the development of life-improving solutions. By intelligently designing and completing trials with critical data, Processa aims to de-risk their approach and increase the probability of success, ultimately benefiting patients and their families.
Generated from the website